Finance

Lists
Why is 4892 down 3.18%?
Dive Deeper
4892:TYO
Cyfuse Biomedical KK
¥487.00
-3.18%
(-16.00) 1D
Nov 20, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4892...
Open
¥500
High
¥503
Low
¥482
Mkt. cap
4.91B
Avg. vol.
41.07K
Volume
69.40K
52-wk high
¥764
52-wk low
¥482
EPS
-¥78
No. of employees
23
Open
¥500
High
¥503
Low
¥482
Mkt. cap
4.91B
Avg. vol.
41.07K
Volume
69.40K
52-wk high
¥764
52-wk low
¥482
EPS
-¥78
No. of employees
23
News stories
From web sources and news partners
About Cyfuse Biomedical KK
CEO-
Employees23
FoundedAug 11, 2010
Headquarters-
SectorHealth Care
Industry-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
169.00M
28.00M
76.00M
10.00M
Cost of goods sold
81.00M
8.00M
31.00M
4.00M
Cost of revenue
81.00M
8.00M
31.00M
4.00M
Research and development expenses
416.00M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-203.00M
236.00M
246.00M
216.00M
Operating expense
227.00M
236.00M
246.00M
216.00M
Total operating expenses
308.00M
244.00M
277.00M
220.00M
Operating income
-139.00M
-216.00M
-201.00M
-210.00M
Other non operating income
20.00M
-3.00M
-5.00M
-3.00M
EBT including unusual items
-125.00M
-224.00M
-209.00M
-216.00M
EBT excluding unusual items
-125.00M
-224.00M
-209.00M
-216.00M
Income tax expense
1.00M
-
1.00M
-
Effective tax rate
-0.80%
-
-0.48%
-
Other operating expenses
-
-
-
-
Net income
-126.00M
-224.00M
-210.00M
-216.00M
Net profit margin
-74.56%
-800.00%
-276.32%
-2,160.00%
Earnings per share
-
-
-
-
Interest and investment income
-
1.00M
2.00M
3.00M
Interest expense
-6.00M
-6.00M
-5.00M
-6.00M
Net interest expenses
-6.00M
-5.00M
-3.00M
-3.00M
Depreciation and amortization charges
14.00M
-
-
-
EBITDA
-129.75M
-206.75M
-194.50M
-200.75M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps